Safety and Efficacy Study Comparing 3 New Types of Coronary Stents
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2291 participants.
Also called NCT01166685
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,291 participants
- Registry
-
NCT01166685
-
- Other papers using this trial's data
- Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Austria, Denmark, Germany, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT01166685. Randomized; no masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2014-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy Study Comparing 3 New Types of Coronary Stents
- Condition
- Coronary Artery Disease
- Condition
- Coronary Thrombosis
- Intervention (Device)
- Everolimus-eluting stent
- Intervention (Device)
- Bare-metal stent
- Intervention (Device)
- Biodegradable Polymer-DES
- Lead sponsor
- University Hospital, Basel, Switzerland
Record details
- Record id
cardio:ct-nct01166685- Content hash
e5aef25246eeb59f9f50986a49fc2cd12d6455270b72e45ee295f9cf589e747e